Cardiovascular Function Following Acute Volume Overload for Hydrodynamic Gene Delivery to the Liver
Overview
Affiliations
Hydrodynamic gene delivery to the liver is a valuable experimental tool and an attractive option for nonviral gene therapy of liver disease. However, little attention has been paid to the major obstacle to clinical application: acute volume overload of the cardiovascular system. We delivered volumes of DNA solution (pGL3 plasmid) corresponding to 1, 2, 4, 6 and 8% of the body weight at 100 ml/min to the inferior vena cava (IVC) of DA strain rats. Central venous pressure (CVP), arterial pressure, pulse and electrocardiogram (ECG) were continuously recorded for subsequent analysis. Each volume produced a characteristic response, but all (including the 1% volume) caused severe falls in blood pressure and pulse within 1-2 s of the infusion, with ectopic beats and widening of the QRS complex in the ECG. The response to volumes of 4% and higher suggested that the liver acted as a volume sink, mitigating the immediate effects of volume overload. The 6 and 8% volumes caused profound and protracted falls in blood pressure and pulse, with a multitude of severe electrical abnormalities in the heart, including electromechanical dissociation. Vagal blockade with atropine, and the use of Ringer's solution to prevent electrolyte disturbances, did not ameliorate this picture.
OBSERVE: guidelines for the refinement of rodent cancer models.
De Vleeschauwer S, van de Ven M, Oudin A, Debusschere K, Connor K, Byrne A Nat Protoc. 2024; 19(9):2571-2596.
PMID: 38992214 DOI: 10.1038/s41596-024-00998-w.
Severity Classification of Laboratory Animal Procedures in Two Belgian Academic Institutions.
De Vleeschauwer S, Lambaerts K, Hernot S, Debusschere K Animals (Basel). 2023; 13(16).
PMID: 37627373 PMC: 10451636. DOI: 10.3390/ani13162581.
Delivery Approaches for Therapeutic Genome Editing and Challenges.
Ates I, Rathbone T, Stuart C, Bridges P, Cottle R Genes (Basel). 2020; 11(10).
PMID: 32977396 PMC: 7597956. DOI: 10.3390/genes11101113.
Validation of Hepatocellular Carcinoma Experimental Models for TGF-β Promoting Tumor Progression.
Mancarella S, Krol S, Crovace A, Leporatti S, Dituri F, Frusciante M Cancers (Basel). 2019; 11(10).
PMID: 31600917 PMC: 6826694. DOI: 10.3390/cancers11101510.
Sendra L, Miguel A, Perez-Enguix D, Herrero M, Montalva E, Garcia-Gimeno M PLoS One. 2016; 11(10):e0163898.
PMID: 27695064 PMC: 5047531. DOI: 10.1371/journal.pone.0163898.